What happened
Routine IVUS-guided PCI fails to reduce target-vessel failure vs angiography alone in complex high-risk patients.
Why the trial, key points, tables, limitations, PICO, abstract, media & sources
Why the trial?
The IVUS CHIP trial was conducted to address the limited evidence from European practice regarding the benefits of intravascular ultrasound (IVUS) guidance during complex PCI, despite guideline recommendations and low adoption in Western countries. It aimed to compare IVUS-guided PCI with angiography-guided PCI in reducing target-vessel failure.
Does routine IVUS-guided PCI reduce target-vessel failure compared to angiography-guided PCI in patients undergoing complex high-risk PCI?
RCT (n=2,020)
Open-label
Yes
Does routine IVUS-guided PCI reduce target-vessel failure compared to angiography-guided PCI in patients undergoing complex high-risk PCI?
Routine IVUS-guided PCI did not significantly reduce the risk of target-vessel failure compared to angiography-guided PCI in patients undergoing complex high-risk PCI.
No takes yet. Share an insight, caveat, or question.
Expert reaction
NEJM · ACC Annual Scientific Session 2025
0 experts have reacted so far. We show the split once 3 have.
Expert labels are toward IVUS CHIP's result, from named public quotes (n=0). As of Oct 28, 2026.
Captured external expert commentary on this trial, strongest first. Original sources are linked where available.
The IVUS CHIP trial is a European multicenter randomized controlled trial comparing IVUS-guided versus angiography-guided PCI in patients with complex coronary lesions, led by Roberto Diletti from Erasmus Medical Center. Results were presented at ACC.26 and published in NEJM.
“We have yet to fully establish how to leverage the unique information provided by intravascular imaging to guide both the indications for and the execution of PCI in a way that justifies the associated increase in procedural complexity and cost.”
Routine IVUS is not warranted for complex PCI; challenges consensus favoring default imaging to improve clinical outcomes.
BACKGROUND: Intravascular ultrasound (IVUS) guidance during percutaneous coronary intervention (PCI) has been associated with increased stent optimization and reduced adverse events among patients with complex coronary-artery lesions, but adoption of this strategy in Western countries remains low. Although practice guidelines recommend intracoronary imaging for anatomically complex lesions, evidence from current European practice is limited. METHODS: In this investigator-initiated, international, open-label, randomized, controlled trial, we assigned patients undergoing complex PCI to either IVUS-guided PCI, performed with the use of prespecified stent-optimization criteria, or angiography-guided PCI. The primary end point was target-vessel failure, defined as a composite of death from cardiac causes, target-vessel myocardial infarction, or clinically indicated target-vessel revascularization. RESULTS: Of the 2020 patients who underwent randomization, 1010 in the IVUS-guided PCI group and 1009 in the angiography-guided PCI group were included in the primary analysis. The mean age of the patients was 69 years, 79.4% were men, and 27.4% presented with an acute coronary syndrome. The mean procedure duration was 88.8 minutes with IVUS-guided PCI and 66.2 minutes with angiography-guided PCI. Dilation with balloon angioplasty after stent implantation was performed in 91.3% of the IVUS-guided PCI procedures and in 84.5% of the angiography-guided PCI procedures. At a median follow-up of 19.0 months (interquartile range, 15.2 to 23.4), target-vessel failure had occurred in 140 patients (13.9%) in the IVUS-guided PCI group and in 112 patients (11.1%) in the angiography-guided PCI group (hazard ratio, 1.25; 95% confidence interval, 0.97 to 1.60; P = 0.08). Procedural complications occurred in 11.3% of the IVUS-guided PCI procedures and in 10.2% of the angiography-guided PCI procedures. The frequency of adverse events appeared to be similar in the two groups. CONCLUSIONS: Among patients undergoing complex high-risk PCI, a strategy of routine IVUS-guided PCI performed with the use of prespecified stent-optimization criteria was not associated with a lower risk of target-vessel failure than angiography-guided PCI alone. (Funded by Boston Scientific; IVUS-CHIP ClinicalTrials.gov number, NCT04854070.).
Diletti et al. (2026) conducted an RCT in Complex coronary-artery lesions (n=2,020). IVUS-guided PCI vs. Angiography-guided PCI was evaluated on Target-vessel failure (composite of death from cardiac causes, target-vessel myocardial infarction, or clinically indicated target-vessel revascularization) (HR 1.25, 95% CI 0.97 to 1.60, p=0.08). Routine IVUS-guided PCI did not lower the risk of target-vessel failure compared to angiography-guided PCI in patients undergoing complex high-risk PCI (HR 1.25; 95% CI 0.97-1.60; P=0.08).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: